BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards
Recognized for excellence in writing, news, mental health, financial/investment and economics categories
The APEX Awards, now in their 36th year, recognize outstanding work by professional communicators in areas such as graphic design, editorial content, and overall communications excellence. With over 1,100 entries this year, the competition was fierce, making these nine wins a testament to the continued leadership and innovation in the field by BioWorld.
APEX Grand Awards honor outstanding works in each main category and Awards of Excellence recognize exceptional entries in the sub-categories. BioWorld has been recognized in the following 2024 APEX Awards categories:
-
Grand Award - Writing Category:
Annette Boyle , BioWorld MedTechCytovale gets FDA nod for 10-minute sepsis testCytovale Inc. receivedU.S. FDA 510(k) clearance for its Intellisep sepsis test, which can aid in the diagnosis of the often-fatal condition within 10 minutes.Cytovale is one of several companies and collaborations that aim to sharply reduce the time to diagnosis and the mortality rate for sepsis by providing quicker, more informative test results and standardizing protocols. -
Grand Award - Writing Category:
Nuala Moran , BioWorld MedTech, BioWorld, and BioWorld Science
Let there be walk: Onward Medical sees first use of movement-restoring lead
The researchers who enabled patients with spinal cord injuries to walk independently after implanting programmable electrodes below their lesions have now taken things one step further, restoring direct communication from the brain to the spinal cord, enabling the brain rather than an external computer to direct leg movements. -
Award for Publication Excellence - Writing the Entire Issue Category:
Jennifer Boggs ,Karen Carey ,Anette Breindl ,Mari Serebrov ,Marian Chu ,Vinod Kamalakannan ,Lee Landenberger ,Harini Mathavan ,Randy Osborne ,Caroline Richards ,Tamra Sami ,Ann Marie Griffith ,Amanda Lanier
BioWorld -June 6, 2023
This issue exemplifies the typical content delivered every business day, featuring nine stories and a podcast covering global industry news. Highlights include a series A financing for a gene therapy company, phase III data from theAmerican Society of Clinical Oncology conference, an M&A that took a public company private, and a comprehensive infographic on R&D spending. -
Award for Publication Excellence in Design & Illustration – Infographics Category:
Ann Marie Griffith andAmanda Lanier , BioWorld
Top trends in 2023's post-pandemic economy
This infographic provides a visual illustration of the impact that financial investment, licensing deals and M&As have on the biopharma industry's ability to advance innovation. It gives a historical perspective of how 2023 fits into the bigger picture and includes expert commentary and graphics packed with data, assessing the biopharma industry's overall health. -
Awards for Publication Excellence in W
riting - Series Category:
Tamra Sami andMari Serebrov , BioWorld,Anette Breindl , BioWorld Science
Radiopharmaceuticals: The next big disrupter?
Radiopharmaceuticals have been used for a long time for diagnostics, but radiopharma therapies are entering a new era in which they are becoming widely accepted as a key tool in the oncology armamentarium potentially providing patients with a big bump in efficacy with fewer side effects and less damage to healthy tissue. In this eight-part series, BioWorld takes a deep dive into this new treatment modality to explore what the new uses or alternatives are and what the future of radiopharmaceutical therapy might look like. -
Awards for Publication Excellence in
Writing - News Category:
Karen Carey , BioWorld
Wegovy wows investors, sends ripples throughout GLP-1 developer space
Investors have known for some time that the GLP-1 receptor agonist class offers tremendous promise for treating the underserved obesity population worldwide, but news from Novo Nordisk A/S on cardiovascular outcomes data sent a shiver throughout the space. -
Awards for Publication Excellence in
Writing – Mental Health Category:
Anette Breindl , BioWorld Science
ECNP 2023: Boosting fear unlearning is one avenue toward treating PTSD
For most psychiatric illnesses, the precipitating event is mysterious. Many conditions are thought to result from a mix of genetic risk and environmental factors, but the specific trigger remains unknown. In post-traumatic stress disorder (PTSD), the environmental trigger is usually clear. In many cases, it is all the affected individuals can think about. "Intrusive reliving" of the triggering situation is one of the core features of PTSD. -
Awards for Publication Excellence in Writing – Financial and Investment Category:
Amanda Lanier , BioWorld
Larger value, fewer transactions: biopharma deals up modestly while M&As soar 80% in 2023
The landscape of biopharma deals and M&As has seen a transformative shift, with a year-over-year drop in transaction numbers while value has increased. Overall, biopharma deals saw an uptick in value of nearly 6%, and biopharma M&As concurrently soared 80% higher in value than the previous year. -
Awards for Publication Excellence in W
riting – Economics/The Economy Category:
Marian (YoonJee) Chu andTamra Sami , BioWorldAsia biotech ecosystems roaring back in 2023
If the COVID-19 pandemic shocked countries to build self-reliance in biomedical ecosystems, the re-opening of borders in 2023 kickstarted international collaborations to grow major biohubs inAsia . Countries in theAsia Pacific region – includingSingapore ,China ,Japan ,Korea andAustralia – increasingly drew overseas investors and collaborators, helping each country grow national biotech capabilities and expertise.
Join the conversation and mention BioWorld on X at BioWorld, BioWorldMedTech and BioWorldScience or on LinkedIn at BioWorld, BioWorld MedTech and
About BioWorld
With writers and editors stationed around the globe, BioWorld published by Clarivate, reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld has a long tradition of excellence in journalism. Collectively, the news services have been honored with 61 awards dating back to 1998.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Media Contact:
Director,
newsroom@clarivate.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/bioworld-by-clarivate-celebrates-nine-wins-at-2024-apex-awards-302200148.html
SOURCE